查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601307

自行注射藥物市場：按類型、應用、通路、治療領域應用分類 - 全球預測 2025-2030

Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

據預測，2023年自行注射藥品市值為540億美元，預計到2024年將達到606.4億美元，複合年成長率為12.72%，到2030年將達到1248.7億美元。

自行注射藥物市場包括允許患者在沒有專業幫助的情況下皮下注射藥物的設備和技術。該市場的促進因素包括慢性病的增加、對家庭醫療保健的日益重視以及對具有成本效益的治療的需求。自行注射藥物對於治療糖尿病、類風濕性關節炎和多發性硬化症等疾病是必要的，可以為患者提供自主權，並與門診病人治療的轉變保持一致。促進市場成長的關鍵因素包括全球老年人口的增加、生技藥品的進步以及注射設備易用性的提高。開發整合數位健康平台以進行即時監測和依從性的智慧自行注射系統，以及為慢性病發病率迅速上升的新興市場開發產品，都存在機會。然而，先進自行注射系統的高成本、低度開發地區缺乏認知以及患者對針頭的恐懼等挑戰可能會抑制採用率。此外，監管障礙和不平衡的報銷政策也構成了重大障礙。公司可以透過投資以患者為中心的創新來推動成長，這些創新打破傳統界限並滿足特定患者的需求，例如無針注射器和方便用戶使用的應用程式輔助設備。無痛分娩技術的探索和針對首次患者的密集訓練模組可能會改變市場格局。與促進教育舉措的醫療保健提供者合作也可以提高患者的信任和依從性。該市場充滿活力但分散，其特點是存在多個追求技術優勢的主要企業。專注於永續的製造流程和強大的上市後監督系統對於公司應對不斷變化的環境政策和政策至關重要。總體而言，自行注射市場是一個充滿前景的市場，有望實現創新主導成長，特別是透過策略聯盟和技術進步來滿足日益健康意識增強的全球人口的需求。

主要市場統計
基準年[2023] 540億美元
預測年份 [2024] 606.4億美元
預測年份 [2030] 1248.7億美元
複合年成長率（%） 12.72%

市場動態：揭示快速發展的自行注射藥物市場的關鍵市場洞察

供需的動態交互作用正在改變自行注射藥物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病和類風濕性關節炎的快速流行
    • 自行注射藥物在不孕症治療的廣泛應用
  • 市場限制因素
    • 產品召回的潛在風險
  • 市場機會
    • 世界各地政府繼續核准自行注射藥物
    • 自行注射裝置的技術進步
  • 市場挑戰
    • 對自行注射毒品的認知不足與管理挑戰

波特五力：駕馭自行注射藥物市場的策略工具

波特的五力框架是了解自行注射藥物市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更具彈性的市場定位。

PESTLE分析：了解外部對自行注射藥品市場的影響

外部宏觀環境因素在塑造自行注射藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解自行注射藥品市場競爭狀況

對自行注射藥物市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣自行注射藥物市場供應商的績效評估

FPNV 定位矩陣是評估自行注射藥物市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性疾病和類風濕性關節炎的迅速傳播
      • 用於不孕症治療的自行注射藥物的廣泛使用
    • 抑制因素
      • 產品召回的潛在風險
    • 機會
      • 世界各地政府正在核准自行注射
      • 自動注射器的技術進步
    • 任務
      • 與自行注射藥物相關的認知有限和管理挑戰
  • 市場區隔分析
    • 類型：在慢性病管理中越來越偏好筆式注射器
    • 用途：一次性自行注射的使用越來越多，以避免交叉污染的風險
    • 通路：自行注射毒品在網路平台的普及
    • 治療領域的應用：自行注射藥物治療荷爾蒙問題的應用正在擴大
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章自行注射藥品市場：依類型

  • 自動注射器
  • 無針注射器
  • 筆式注射器
  • 穿戴式注射器

第7章自行注射藥品市場應用

  • 一次性的
  • 可重複使用的

第8章自行注射藥品市場：依通路

  • 醫院藥房
  • 網路藥房
  • 私人診所

第9章依治療領域分類的自行注射藥品市場應用

  • 自體免疫疾病
    • 愛滋病
    • 過敏
    • 癌症
    • 腸躁症
    • 多發性硬化症
    • 乾癬
  • 急救藥品
    • 過敏襪
    • 偏頭痛
  • 荷爾蒙補充療法
    • BETA干擾素
    • 促紅血球生成素
    • 濾泡刺激素
    • 肝素
    • 胰島素
    • 副甲狀腺素
    • 帕金森氏症

第10章 美洲自行注射藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太自行注射藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲/中東/非洲自行注射藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 美光生物醫學公司獲得資金生產無針疫苗
    • Enable Injections 首次獲得美國食品藥物管理局(FDA)核准
    • Altaviz 推出新型藥物輸送自動注射器平台
    • FDA核准用於 PNH 治療的自用內置注射器 pegcetacoplan
    • Civica 與 Ipsomed 合作開發胰島素注射筆
    • Eitan Medical完成穿戴式注射器業務轉型
    • Coherus 宣佈在美國推出 UDENYCA 自動注射器
    • Ypsomed 透過綜合人因服務增強自行注射設備平台
    • Viridian Therapeutics 宣布與藥物傳輸創新者 Enable Injections 合作
    • 美國FDA核准Tezspire 使用預填充筆進行自我給藥
    • Philips Medisize 推出筆式注射器平台，擴大產品系列，旨在降低藥品成本、風險和市場壁壘

公司名單

  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • SCHOTT AG
  • Eli Lilly and Company
  • AstraZeneca plc
  • PharmaJet, Inc.
  • West Pharmaceutical Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Terumo Corporation
  • Enable Injections, Inc.
  • Owen Mumford Limited
  • SHL Medical AG
  • Merck KGaA
  • Sanofi SA
  • Recipharm AB
  • DALI Medical Devices Ltd.
  • Credence MedSystems, Inc.
  • Novo Nordisk A/S
  • Mylan NV by Viatris Inc.
  • GlaxoSmithKline plc
  • Gerresheimer AG
  • Medmix AG by Sulzer Ltd.
  • Molex LLC by Koch Industries, Inc.
  • PenJet Corporation
  • Ypsomed Group
  • Baxter International, Inc.
  • Pfizer Inc.
  • Becton, Dickinson and Company
  • Antares Pharma, Inc. by Halozyme, Inc.
  • AbbVie Inc.
Product Code: MRR-03050D1B2DB4

The Self-injections Market was valued at USD 54.00 billion in 2023, expected to reach USD 60.64 billion in 2024, and is projected to grow at a CAGR of 12.72%, to USD 124.87 billion by 2030.

The self-injections market encompasses devices and technologies that enable patients to administer medications subcutaneously without professional assistance. This market is driven by increased chronic disease prevalence, a growing emphasis on home healthcare, and the demand for cost-effective medical treatments. Self-injections are necessary for managing conditions such as diabetes, rheumatoid arthritis, and multiple sclerosis, providing patients with autonomy and aligning with the shift towards outpatient care. Key influencers of market growth include the rising global geriatric population, advances in biologics, and improved usability of injection devices. Opportunities exist in the development of smart self-injection systems that integrate digital health platforms for real-time monitoring and adherence, as well as expanding offerings for emerging markets where chronic diseases are rising rapidly. However, challenges such as high costs of advanced self-injection systems, lack of awareness in underdeveloped regions, and patients' needle anxiety may impede adoption rates. Additionally, regulatory hurdles and variability in reimbursement policies pose significant barriers. Companies can foster growth by investing in patient-centric innovations, such as needle-free injectors and user-friendly app-assisted devices, that break conventional boundaries and cater to specific patient needs. Research into pain-free delivery technologies and enhanced training modules for first-time users could revolutionize the market landscape. Partnerships with healthcare providers to promote educational initiatives can also improve patient confidence and compliance. The market is dynamic but fragmented, characterized by several key players striving for technological superiority. Enhanced focus on sustainable manufacturing processes and robust post-market surveillance systems will be vital as companies align themselves with evolving environmental policies and regulations. Overall, the self-injection market holds promising potential for innovation-led growth, particularly through strategic collaborations and technological advancements that cater to an increasingly health-conscious global population.

KEY MARKET STATISTICS
Base Year [2023] USD 54.00 billion
Estimated Year [2024] USD 60.64 billion
Forecast Year [2030] USD 124.87 billion
CAGR (%) 12.72%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Self-injections Market

The Self-injections Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapid prevalence of chronic diseases and rheumatoid arthritis
    • Wide availability of self-injections for fertility treatments
  • Market Restraints
    • Potential risk of product recall
  • Market Opportunities
    • Ongoing government approvals for self-injections worldwide
    • Technological advancements in self-injection devices
  • Market Challenges
    • Limited awareness and administration challenges associated with self-injections

Porter's Five Forces: A Strategic Tool for Navigating the Self-injections Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Self-injections Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Self-injections Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Self-injections Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Self-injections Market

A detailed market share analysis in the Self-injections Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Self-injections Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Self-injections Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Self-injections Market, highlighting leading vendors and their innovative profiles. These include Insulet Corporation, Johnson & Johnson Services, Inc., SCHOTT AG, Eli Lilly and Company, AstraZeneca plc, PharmaJet, Inc., West Pharmaceutical Services, Inc., Teva Pharmaceutical Industries Ltd., Terumo Corporation, Enable Injections, Inc., Owen Mumford Limited, SHL Medical AG, Merck KGaA, Sanofi S.A., Recipharm AB, DALI Medical Devices Ltd., Credence MedSystems, Inc., Novo Nordisk A/S, Mylan N.V. by Viatris Inc., GlaxoSmithKline plc, Gerresheimer AG, Medmix AG by Sulzer Ltd., Molex LLC by Koch Industries, Inc., PenJet Corporation, Ypsomed Group, Baxter International, Inc., Pfizer Inc., Becton, Dickinson and Company, Antares Pharma, Inc. by Halozyme, Inc., and AbbVie Inc..

Market Segmentation & Coverage

This research report categorizes the Self-injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Auto-Injectors, Needle-free Injectors, Pen Injectors, and Wearable Injectors.
  • Based on Usage, market is studied across Disposable and Reusable.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Private Clinics.
  • Based on Therapeutic Areas Application, market is studied across Autoimmune Diseases, Emergency Drugs, and Hormone Replacement Therapies. The Autoimmune Diseases is further studied across AIDS, Allergies, Cancer, Irritable Bowel Disorders, Multiple Sclerosis, and Psoriasis. The Emergency Drugs is further studied across Anaphylactic Socks and Migraine. The Hormone Replacement Therapies is further studied across Beta-Interferon, Erythropoietin, Follicle Stimulating Hormone, Heparin, Insulin, Parathyroid Hormone, and Parkinson's.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid prevalence of chronic diseases and rheumatoid arthritis
      • 5.1.1.2. Wide availability of self-injections for fertility treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk of product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing government approvals for self-injections worldwide
      • 5.1.3.2. Technological advancements in self-injection devices
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and administration challenges associated with self-injections
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising preference for pen injectors to manage chronic diseases
    • 5.2.2. Usage: Growing use of disposable self-injections to avoid the risk of cross-contamination
    • 5.2.3. Distribution Channel: Emerging penetration of self-injections on online platforms
    • 5.2.4. Therapeutic Areas Application: Growing applications of self-injections to treat hormonal issues
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Self-injections Market, by Type

  • 6.1. Introduction
  • 6.2. Auto-Injectors
  • 6.3. Needle-free Injectors
  • 6.4. Pen Injectors
  • 6.5. Wearable Injectors

7. Self-injections Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Self-injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Private Clinics

9. Self-injections Market, by Therapeutic Areas Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
    • 9.2.1. AIDS
    • 9.2.2. Allergies
    • 9.2.3. Cancer
    • 9.2.4. Irritable Bowel Disorders
    • 9.2.5. Multiple Sclerosis
    • 9.2.6. Psoriasis
  • 9.3. Emergency Drugs
    • 9.3.1. Anaphylactic Socks
    • 9.3.2. Migraine
  • 9.4. Hormone Replacement Therapies
    • 9.4.1. Beta-Interferon
    • 9.4.2. Erythropoietin
    • 9.4.3. Follicle Stimulating Hormone
    • 9.4.4. Heparin
    • 9.4.5. Insulin
    • 9.4.6. Parathyroid Hormone
    • 9.4.7. Parkinson's

10. Americas Self-injections Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Self-injections Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Self-injections Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Micron Biomedical Receives Funds To Produce Needle-Free Vaccines
    • 13.3.2. Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
    • 13.3.3. Altaviz introduces New Auto-Injector Platform For Drug Delivery
    • 13.3.4. FDA Approves On-Body Injector for Self Administration of Pegcetacoplan for PNH
    • 13.3.5. Civica Partners With Ypsomed For Insulin Injection Pen
    • 13.3.6. Eitan Medical Completes Transition of Wearable Injectors Business
    • 13.3.7. Coherus Announces U.S. Launch of UDENYCA Autoinjector
    • 13.3.8. Ypsomed Enhances Self-Injection Device Platforms With Integrated Human Factors Services
    • 13.3.9. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
    • 13.3.10. US FDA Approves Tezspire For Self-Administration Using Pre-Filled Pen
    • 13.3.11. Phillips-Medisize Expands Product Portfolio with Launch of a Pen Injector Platform Designed to Lower Pharma Costs, Risks and Market Barriers

Companies Mentioned

  • 1. Insulet Corporation
  • 2. Johnson & Johnson Services, Inc.
  • 3. SCHOTT AG
  • 4. Eli Lilly and Company
  • 5. AstraZeneca plc
  • 6. PharmaJet, Inc.
  • 7. West Pharmaceutical Services, Inc.
  • 8. Teva Pharmaceutical Industries Ltd.
  • 9. Terumo Corporation
  • 10. Enable Injections, Inc.
  • 11. Owen Mumford Limited
  • 12. SHL Medical AG
  • 13. Merck KGaA
  • 14. Sanofi S.A.
  • 15. Recipharm AB
  • 16. DALI Medical Devices Ltd.
  • 17. Credence MedSystems, Inc.
  • 18. Novo Nordisk A/S
  • 19. Mylan N.V. by Viatris Inc.
  • 20. GlaxoSmithKline plc
  • 21. Gerresheimer AG
  • 22. Medmix AG by Sulzer Ltd.
  • 23. Molex LLC by Koch Industries, Inc.
  • 24. PenJet Corporation
  • 25. Ypsomed Group
  • 26. Baxter International, Inc.
  • 27. Pfizer Inc.
  • 28. Becton, Dickinson and Company
  • 29. Antares Pharma, Inc. by Halozyme, Inc.
  • 30. AbbVie Inc.

LIST OF FIGURES

  • FIGURE 1. SELF-INJECTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. SELF-INJECTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SELF-INJECTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SELF-INJECTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON'S, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 332. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 333. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023